Dissolution Solutions Network

A New Paradigm for Drug Discovery

dissol — Thu, 16 May 2013 12:05:54 +0000

“Crowdfunding has revitalized project financing. Science is next. Crowdfunding is the newest innovation in financing, all thanks to the unprecedented access to information through the Internet.

Rare Genomics Institute is helping children with rare disease. PetrDish and Microryza are finding funding for research. Community laboratories are opening up to allow amateur scientists to test their ideas cheaply. more…“

NOVARTIS AG VERSUS UNION OF INDIA

dissol — Tue, 02 Apr 2013 12:08:11 +0000

IN THE SUPREME COURT OF INDIA
CIVIL APPELLATE JURISDICTION
CIVIL APPEAL Nos. 2706-2716 OF 2013
(ARISING OUT OF SLP(C) Nos. 20539-20549 OF 2009)
NOVARTIS AG ….APPELLANT
VERSUS
UNION OF INDIA & OTHERS ….RESPONDENTS
more…

New Tools in the War on Cancer

dissol — Tue, 19 Mar 2013 12:14:33 +0000

“Every available cancer drug is susceptible to resistance, according to Mansoor Amiji, Distinguished Professor and chair of the Department of Pharmaceutical Sciences. Tumors grow more quickly than blood vessels, so these unruly masses of cells receive very little oxygen and nutrients, which means they know just how to survive under harsh conditions. They make miniature pumps to actively dispel anything that doesn’t serve them well (like drugs), and … more“

India revokes patent on Merck & Co asthma drug

dissol — Wed, 12 Dec 2012 13:19:16 +0000

“India has revoked a patent granted to an asthma drug made by Schering Corp, later bought by U.S.-based Merck & Co (MRK.N), citing lack of invention, after Indian drugmaker Cipla Ltd (CIPL.NS) challenged an earlier decision.”

“The move is the latest in a series of patent cancellations by India, where …http://in.reuters.com/article/2012/12/11/india-merck-patent-idINDEE8BA09Y20121211“

Ameridose’s 483

dissol — Wed, 14 Nov 2012 13:10:08 +0000

I just read Ameridose’s 483.

Wow! It speaks for itself.

FDA Urged to Speed Approval of Drugs

dissol — Fri, 28 Sep 2012 12:06:58 +0000

“A White House advisory body on Tuesday unveiled a plan to double the number of new prescription drugs that go on the market each year by more quickly approving drugs to treat high-risk patients.

The President’s Council of Advisors on Science and Technology urged the Food and Drug Administration to expand its use of faster drug approvals to a wider range of diseases. The council suggested the FDA could begin to approve drugs that may help only a narrow and high-risk patient population, such as people who are morbidly obese, under what the council called “special medical use” approvals.

The advisory report gave few details of what new laws or …more“

31 Drugs Facing FDA Approval in 2012-2013

dissol — Tue, 21 Aug 2012 12:03:02 +0000

“Here’s an updated list of biotech and pharmaceutical companies with pending FDA drug approval decisions for the rest of 2012 and into early 2013. This refresh includes changes and additions to the FDA calendar last published at the end of July. ” http://www.thestreet.com/story/11668461/1/31-drugs-facing-fda-approval-in-2012-2013.html

UK overhauls drug laws with new Human Medicines Regulations

dissol — Mon, 20 Aug 2012 12:46:45 +0000

New Human Medicines Regulations came into effect this morning, overhauling the UK’s regulations on drug manufacturing, importation, distribution, packaging and pharmacovigilance.

http://www.in-pharmatechnologist.com/Regulatory-Safety/UK-overhauls-drug-laws-with-new-Human-Medicines-Regulations

A Total Mess at the FDA?

dissol — Thu, 26 Jul 2012 12:19:44 +0000

Derek Lowe, writes for “In the Pipeline”. Check out his investigation of the total mess at the FDA and employee surveillance scandal to brew! Wow, I hope these stories aren’t true. It sounds like a terrible place to work, with many other issues to boot.

Top Secret Writers writes “A hugely damning report published by the New York Times blew the lid on a secret FDA surveillance conspiracy.
What started in 2010 as a small-scale investigation of five FDA scientists suspected of leaking confidential agency information, rapidly escalated into a much more comprehensive surveillance campaign.”

No action taken to withdraw 33 untested drugs from market after one month

dissol — Thu, 14 Jun 2012 12:10:43 +0000

“Even though one month has passed since the Parliamentary Standing Committee on Health’s startling revelations that the Drug Controller General of India (DCGI) has approved as much as 33 drugs without clinical trial on Indian patients during the period of January 2008 to October 2010, all the controversial drugs are still in the market with the Indian regulator contemplating no action on the issue in the immediate future…more“

US clears drugs faster than Europe, Canada

dissol — Fri, 18 May 2012 12:04:56 +0000

“Researchers say the U.S. approved more new medicines in less time than Europe and Canada in the last decade, challenging long-standing criticisms that the Food and Drug Administration lags behind its peers in clearing important new drugs…more“

EMA extends real-time release testing role in new guidelines

dissol — Tue, 17 Apr 2012 12:06:19 +0000

The EMA has released guidelines extending use of real-time release testing (RTRT) beyond terminally sterilised products…
http://www.in-pharmatechnologist.com/Processing-QC/EMA-extends-real-time-release-testing-role-in-new-guidelines

Chairman of top EU drugs committee quits

dissol — Fri, 06 Apr 2012 12:12:33 +0000

“The chairman of the European Medicines Agency’s main committee for approving new drugs resigned on Wednesday after his position at the French healthcare regulator AFSSAPS was eliminated. Eric Abadie’s resignation as chairman of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) took effect immediately…more“

GlaxoSmithKline to raise average UK salaries by 4%

dissol — Thu, 15 Mar 2012 12:19:42 +0000

In a sign that the economy is recovering…”GlaxoSmithKline (GSK) will raise its UK employees’ average salaries by around 4% in 2012. In the GSK annual report 2011, published on 12 March, the pharmaceutical firm also said it will raise average US employees’ salaries by …more“

Spring 2012 ACS National Exposition

dissol — Thu, 01 Mar 2012 13:23:04 +0000

It looks like I’ll be in Europe while this one is going on. This looks like a great Expo. Oh well, next time…

San Diego Convention Center
Dates: March 25-29, 2012
Location: San Diego, California, USA
Theme: Chemistry of Life

ACS’ 243rd National Meeting & Exposition will host more than 11,700 presentations on new discoveries that span science’s horizons — from astronomy to zoology. Topics include:
•Food and nutrition
•Medicine
•Health
•Energy
•The environment
•Other fields where chemistry plays a central role in preventing and combating disease

More Info…